Remission of refractory Crohn's disease with anti-IL-12/23 therapy in a patient undergoing hemodialysis: A case report.

Spathakis, Michail; Filidou, Eirini; Kolios, George; Papazoglou, Dimitrios; Vradelis, Stergios

Spathakis, Michail; Filidou, Eirini; Kolios, George; Papazoglou, Dimitrios; Vradelis, Stergios.

Afiliação

Spathakis M; Laboratory of Pharmacology, Faculty of Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
Filidou E; Laboratory of Pharmacology, Faculty of Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
Kolios G; Laboratory of Pharmacology, Faculty of Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
Papazoglou D; Department of Internal Medicine, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
Vradelis S; Department of Internal Medicine, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.

Hemodial Int ; 27(3): E41-E44, 2023 07.

Article em En | MEDLINE | ID: mdl-37313986

Assuntos

Doença de Crohn; Feminino; Humanos; Pessoa de Meia-Idade; Doença de Crohn/complicações; Doença de Crohn/tratamento farmacológico; Interleucina-12/uso terapêutico; Indução de Remissão; Diálise Renal; Ustekinumab/uso terapêutico; Resultado do Tratamento

Palavras-chave

Crohn's disease; anti-IL-12/23; case report; hemodialysis; ustekinumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google